Karolinska Mammography Project for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

Karolinska Mammography Projectfor Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

The Karma research group at Karolinska Institutet is creating the world’s best-characterised breast cancer cohort. The aim is to reduce the mortality and incidence in breast cancer through translational research focusing on breast cancer screening and prevention.

The Karma research group at Karolinska Institutet is creating the world’s best-characterised breast cancer cohort. The aim is to reduce the mortality and incidence in breast cancer through translational research focusing on breast cancer screening and prevention.

Recent news

2018-11-19

Around 62,000 Karma participants have recently received emails regarding strategies for breast cancer risk communication. The Karma group aim to collect questionnaire data from the Karma participants on whether they want to know about their individual risk of breast cancer, and if so, how and by whom the risk should be communicated to the women. ...

2018-09-10

The Karma CREME-1 phase 2 clinical trial on topical endoxifen for preventive treatment of women with mammographic breast density is now open for inclusion. The study will include 90 participants and each participant will use topical endoxifen for six months. Preliminary results are expected during spring 2019. ...